SI2416794T1 - Rastlinska sestava za zdravljenje ali preprečevanje virusnih bolezni, ki se prenašajo s krvjo, ki jih povzroči virus človeške imunske pomanjkljivosti (HIV) ali hepatitis C - Google Patents

Rastlinska sestava za zdravljenje ali preprečevanje virusnih bolezni, ki se prenašajo s krvjo, ki jih povzroči virus človeške imunske pomanjkljivosti (HIV) ali hepatitis C

Info

Publication number
SI2416794T1
SI2416794T1 SI200930874T SI200930874T SI2416794T1 SI 2416794 T1 SI2416794 T1 SI 2416794T1 SI 200930874 T SI200930874 T SI 200930874T SI 200930874 T SI200930874 T SI 200930874T SI 2416794 T1 SI2416794 T1 SI 2416794T1
Authority
SI
Slovenia
Prior art keywords
hepatitis
hiv
prevention
treatment
immunodeficiency virus
Prior art date
Application number
SI200930874T
Other languages
English (en)
Inventor
Kettany Sleimen El
Original Assignee
Kettany Sleimen El
El Khatib Nadia Bonja & Khoukaz Building
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kettany Sleimen El, El Khatib Nadia Bonja & Khoukaz Building filed Critical Kettany Sleimen El
Publication of SI2416794T1 publication Critical patent/SI2416794T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SI200930874T 2009-04-10 2009-04-10 Rastlinska sestava za zdravljenje ali preprečevanje virusnih bolezni, ki se prenašajo s krvjo, ki jih povzroči virus človeške imunske pomanjkljivosti (HIV) ali hepatitis C SI2416794T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR2009/050678 WO2010116048A1 (fr) 2009-04-10 2009-04-10 Composition à base de plantes pour le traitement ou la prévention de maladies virales du sang telles que les maladies causées par le virus de l' immunodéficience humaine (vih) ou l'hépatite c
EP09784375.9A EP2416794B1 (fr) 2009-04-10 2009-04-10 Composition à base de plantes pour le traitement ou la prévention de maladies virales du sang causées par le virus de l' immunodéficience humaine (vih) ou l'hépatite c

Publications (1)

Publication Number Publication Date
SI2416794T1 true SI2416794T1 (sl) 2014-05-30

Family

ID=41723043

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200930874T SI2416794T1 (sl) 2009-04-10 2009-04-10 Rastlinska sestava za zdravljenje ali preprečevanje virusnih bolezni, ki se prenašajo s krvjo, ki jih povzroči virus človeške imunske pomanjkljivosti (HIV) ali hepatitis C

Country Status (16)

Country Link
US (1) US20120076849A1 (sl)
EP (1) EP2416794B1 (sl)
JP (1) JP5472445B2 (sl)
CN (1) CN102458432B (sl)
AU (1) AU2009344046B2 (sl)
CA (1) CA2758365A1 (sl)
CY (1) CY1115326T1 (sl)
DK (1) DK2416794T3 (sl)
ES (1) ES2452482T3 (sl)
HR (1) HRP20140230T8 (sl)
PL (1) PL2416794T3 (sl)
PT (1) PT2416794E (sl)
RS (1) RS53216B (sl)
RU (1) RU2543319C2 (sl)
SI (1) SI2416794T1 (sl)
WO (1) WO2010116048A1 (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2973249B1 (fr) * 2011-03-28 2014-02-07 Centre Nat Rech Scient Utilisation de l'epigallocatechine gallate comme agent antiviral contre les infections par le virus de l'hepatite c
KR101899122B1 (ko) * 2017-04-20 2018-09-21 주식회사 제넨셀 C형 간염 바이러스 감염 질환의 예방 또는 치료용 약학 조성물
EP4146227A4 (en) * 2020-05-04 2024-01-24 Sulfagenix Inc TREATMENT OF VIRUS INFECTIONS

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US202932A (en) * 1878-04-30 Improvement in hog-cholera compounds
FR2296426A1 (fr) * 1975-01-03 1976-07-30 Durupt Marie Helene Elixir
US4692342A (en) * 1985-11-14 1987-09-08 Nabisco Brands, Inc. Process for honey-roasting nuts
JPH0683635B2 (ja) * 1986-03-28 1994-10-26 株式会社ロツテ 抗菌作用の増強されたかりんエキスを配合した菓子類
FR2619716B1 (fr) * 1987-08-26 1991-02-08 Letourneur Bernard Medicament et produit veterinaire pour le traitement de la sterilite
FR2622800B1 (fr) * 1987-11-05 1990-03-23 Hauser Denis Procede de preparation d'un produit de lutte contre des affections virales en particulier des affections virales cutaneo-muqueuses,compositions pharmaceutiques et medicaments obtenus a partir de ce procede
JPH02270824A (ja) * 1989-04-13 1990-11-05 Snow Brand Milk Prod Co Ltd 逆転写酵素阻害剤
US5411733A (en) * 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
AU6037494A (en) * 1993-02-26 1994-09-14 Ina Levi Use of active substances in the therapy of certain diseases, process for preparing a pharmaceutical composition for that purpose and pharmaceutical compositions thus prepared
CN1300623A (zh) * 1999-12-20 2001-06-27 张发平 一种中成药
US6641801B1 (en) * 2000-04-03 2003-11-04 Love Lives Gargle method to reduce the duration of common cold symptoms
US6841174B2 (en) * 2000-09-20 2005-01-11 Zeyad Technologies Llc Herbal compositions and treatment methods
WO2002096405A1 (fr) * 2001-05-25 2002-12-05 Ssp Co., Ltd. Preparations de medicaments
GEP20032886B (en) * 2001-08-22 2003-02-25 Maka Burdiladze Plant Species for Treatment of Chronic Hepatite
KR20010099494A (ko) * 2001-10-09 2001-11-09 이영성, 권두한 큰등골짚신나물로부터 분리한 ｂ형 간염바이러스 표면항원억제물질과 그 추출방법 및 용도
KR100525339B1 (ko) * 2002-06-29 2005-11-02 바이오코리아 주식회사 (ｅ)-1-[[(2ｅ,4ｅ)-1-헥실-2,4-옥타데카디에닐]옥시]-2-하이드록시디아진 화합물 및 이를 포함하는 간염 치료제조성물
JP2004161623A (ja) * 2002-11-11 2004-06-10 Noevir Co Ltd 水性スティック状抗アクネ用組成物
DE202005007603U1 (de) * 2005-05-13 2005-08-04 HD Health Development GmbH Zusammensetzung umfassend eine Kombination aus Arganöl und Schwarzkümmelöl
FR2901699A1 (fr) * 2006-06-06 2007-12-07 Christian Maret Compositions dont les proprietes sont dues a l'association d'elements synergises, leur procede de preparation et leurs utilisations en cosmetique ou hygiene

Also Published As

Publication number Publication date
ES2452482T3 (es) 2014-04-01
CY1115326T1 (el) 2017-01-04
WO2010116048A8 (fr) 2011-11-10
RU2543319C2 (ru) 2015-02-27
AU2009344046A1 (en) 2011-11-10
CN102458432A (zh) 2012-05-16
WO2010116048A1 (fr) 2010-10-14
JP5472445B2 (ja) 2014-04-16
EP2416794A1 (fr) 2012-02-15
RS53216B (en) 2014-08-29
PT2416794E (pt) 2014-03-17
RU2011143088A (ru) 2013-05-10
CN102458432B (zh) 2015-04-22
JP2012523396A (ja) 2012-10-04
AU2009344046B2 (en) 2014-10-30
HRP20140230T8 (hr) 2015-12-04
HRP20140230T1 (hr) 2014-05-09
EP2416794B1 (fr) 2013-12-25
US20120076849A1 (en) 2012-03-29
PL2416794T3 (pl) 2014-09-30
CA2758365A1 (fr) 2010-10-14
DK2416794T3 (en) 2014-03-17

Similar Documents

Publication Publication Date Title
WO2010118367A3 (en) Antiviral pyrimidines
WO2011007230A3 (en) Lupeol-type triterpene derivatives as antivirals
IL217243A (en) Theophane 2-carboxylic acid derivatives, including pharmaceutical preparations and their uses for the preparation of flaviviridiae virus infections and hepatitis c virus infections
MX346264B (es) Compuestos antivirales.
EP2853531A3 (en) Antiviral compounds
MY170941A (en) Pyrimidine derivatives for the treatment of viral infections
MX2013003634A (es) Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales.
HK1197026A1 (en) Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection
LT2408476T (lt) Žmogaus imunodeficito virusą (živ) neutralizuojantys antikūnai
WO2009094190A3 (en) Methods of treating viral infections
SG179082A1 (en) Method for the preparation of an influenza virus
MX2013000242A (es) Tratamiento de enfermedades relacionadas con el virus de hepatitis c que usa hidroxicloroquina o una combinacion de hidroxicloroquina y un agente antiviral.
JO3281B1 (ar) مركبات بينزوفوران لمعالجة عدوى فيروس إلتهاب الكبد الوبائي
EP2555798A4 (en) METHOD AND COMPOSITIONS FOR INHIBITING HIV TRANSMISSIONS
HRP20140230T8 (hr) Biljna kompozicija za lijeäśenje ili prevenciju virusnih bolesti koje se prenose putem krvi, kao što su bolesti izazvane virusom humane imunodeficijencije (hiv) ili hepatitis c virusom
HK1201262A1 (en) Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection (hcv)
MX2011006516A (es) Terapia de combinacion de virus de hepatitis c.
MY171497A (en) Crystalline forms of dihydropyrimidine derivatives
GB2463584A (en) Carbohydrate-lipid constructs and their use in preventing or treating viral infection
GB201008123D0 (en) Novel compounds
PL391694A1 (pl) Modyfikowane 2',3'-dideoksynukleozydy do leczenia zakażeń szczepami ludzkiego wirusa nabytego niedoboru odporności (HIV) wykazującymi oporność wielolekową, sposób ich wytwarzania oraz środek farmaceutyczny zawierający te nukleozydy